Your browser doesn't support javascript.
loading
Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.
Jiskoot, Lize C; Bocchetta, Martina; Nicholas, Jennifer M; Cash, David M; Thomas, David; Modat, Marc; Ourselin, Sebastien; Rombouts, Serge A R B; Dopper, Elise G P; Meeter, Lieke H; Panman, Jessica L; van Minkelen, Rick; van der Ende, Emma L; Donker Kaat, Laura; Pijnenburg, Yolande A L; Borroni, Barbara; Galimberti, Daniela; Masellis, Mario; Tartaglia, Maria Carmela; Rowe, James; Graff, Caroline; Tagliavini, Fabrizio; Frisoni, Giovanni B; Laforce, Robert; Finger, Elizabeth; de Mendonça, Alexandre; Sorbi, Sandro; Papma, Janne M; van Swieten, John C; Rohrer, Jonathan D.
Afiliação
  • Jiskoot LC; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Bocchetta M; Dementia Research Center University College London London United Kingdom.
  • Nicholas JM; Department of Radiology Leiden University Medical Center Leiden the Netherlands.
  • Cash DM; Dementia Research Center University College London London United Kingdom.
  • Thomas D; Dementia Research Center University College London London United Kingdom.
  • Modat M; Department of Medical Statistics London School of Hygiene & Tropical Medicine London United Kingdom.
  • Ourselin S; Dementia Research Center University College London London United Kingdom.
  • Rombouts SARB; Centre for Medical Image Computing (CMIC) University College London London United Kingdom.
  • Dopper EGP; Dementia Research Center University College London London United Kingdom.
  • Meeter LH; Centre for Medical Image Computing (CMIC) University College London London United Kingdom.
  • Panman JL; Dementia Research Center University College London London United Kingdom.
  • van Minkelen R; Centre for Medical Image Computing (CMIC) University College London London United Kingdom.
  • van der Ende EL; Dementia Research Center University College London London United Kingdom.
  • Donker Kaat L; Centre for Medical Image Computing (CMIC) University College London London United Kingdom.
  • Pijnenburg YAL; Department of Radiology Leiden University Medical Center Leiden the Netherlands.
  • Borroni B; Institute of Psychology Leiden University Leiden the Netherlands.
  • Galimberti D; Leiden Institute for Brain and Cognition Leiden University Leiden the Netherlands.
  • Masellis M; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Tartaglia MC; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Rowe J; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Graff C; Department of Radiology Leiden University Medical Center Leiden the Netherlands.
  • Tagliavini F; Department of Clinical Genetics Erasmus Medical Center Rotterdam the Netherlands.
  • Frisoni GB; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Laforce R; Department of Radiology Leiden University Medical Center Leiden the Netherlands.
  • Finger E; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • de Mendonça A; Department of Clinical Genetics Leiden University Medical Center Leiden the Netherlands.
  • Sorbi S; Department of Neurology Alzheimer Center Neuroscience Campus Amsterdam Amsterdam the Netherlands.
  • Papma JM; Department of Pathophysiology and Transplantation Dino Ferrari Center University of Milan Fondazione Ca` Granda IRCCS Ospedale Maggiore Policlinico Milan Italy.
  • van Swieten JC; LC Campbell Cognitive Neurology Research Unit Sunnybrook Research Institute Toronto Ontario Canada.
  • Rohrer JD; Tanz Centre for Research in Neurodegenerative Diseases University of Toronto Toronto Ontario Canada.
Ann Clin Transl Neurol ; 5(9): 1025-1036, 2018 09.
Article em En | MEDLINE | ID: mdl-30250860
ABSTRACT

Objective:

We aimed to investigate mutation-specific white matter (WM) integrity changes in presymptomatic and symptomatic mutation carriers of the C9orf72,MAPT, and GRN mutations by use of diffusion-weighted imaging within the Genetic Frontotemporal dementia Initiative (GENFI) study.

Methods:

One hundred and forty mutation carriers (54 C9orf72, 30 MAPT, 56 GRN), 104 presymptomatic and 36 symptomatic, and 115 noncarriers underwent 3T diffusion tensor imaging. Linear mixed effects models were used to examine the association between diffusion parameters and years from estimated symptom onset in C9orf72,MAPT, and GRN mutation carriers versus noncarriers. Post hoc analyses were performed on presymptomatic mutation carriers only, as well as left-right asymmetry analyses on GRN mutation carriers versus noncarriers.

Results:

Diffusion changes in C9orf72 mutation carriers are present significantly earlier than both MAPT and GRN mutation carriers - characteristically in the posterior thalamic radiation and more posteriorly located tracts (e.g., splenium of the corpus callosum, posterior corona radiata), as early as 30 years before estimated symptom onset. MAPT mutation carriers showed early involvement of the uncinate fasciculus and cingulum, sparing the internal capsule, whereas involvement of the anterior and posterior internal capsule was found in GRN. Restricting analyses to presymptomatic mutation carriers only, similar - albeit less extensive - patterns were found posteriorly located WM tracts (e.g., posterior thalamic radiation, splenium of the corpus callosum, posterior corona radiata) in presymptomatic C9orf72, the uncinate fasciculus in presymptomatic MAPT, and the internal capsule (anterior and posterior limbs) in presymptomatic GRN mutation carriers. In GRN, most tracts showed significant left-right differences in one or more diffusion parameter, with the most consistent results being found in the UF, EC, RPIC, and ALIC.

Interpretation:

This study demonstrates the presence of early and widespread WM integrity loss in presymptomatic FTD, and suggests a clear genotypic "fingerprint." Our findings corroborate the notion of FTD as a network-based disease, where changes in connectivity are some of the earliest detectable features, and identify diffusion tensor imaging as a potential neuroimaging biomarker for disease-tracking and -staging in presymptomatic to early-stage familial FTD.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article